Bluebird Bio reported $903.53M in Current Assets for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
Acceleron Pharma XLRN:US $ 717.77M 19.84M
Agios Pharmaceuticals AGIO:US $ 1702.56M 652.55M
Alexion Pharmaceuticals ALXN:US $ 6452.6M 619.6M
Alnylam Pharmaceuticals ALNY:US $ 2725.16M 255.08M
Amgen AMGN:US $ 19099M 2200M
Applied Genetic Technologies AGTC:US $ 109.71M 3.32M
Arrowhead Research ARWR:US $ 525.96M 60.8M
Avrobio Inc AVRO:US 233.52M 8.54M
Biogen BIIB:US $ 7183.7M 464.2M
Biomarin Pharmaceutical BMRN:US $ 2357.84M 69.07M
Bluebird Bio BLUE:US $ 903.53M 194.01M
Dicerna Pharmaceuticals DRNA:US $ 616.49M 21.99M
Gilead Sciences GILD:US $ 14498M 1220M
Immunogen IMGN:US $ 274.4M 45.18M
Intercept Pharmaceuticals ICPT:US $ 493.1M 5.54M
IONIS PHARMACEUT IONS:US $ 2238.42M 249M
Mirati Therapeutics MRTX:US $ 1278.09M 25.42M
Moderna Inc MRNA:US 10.97B 734M
Nektar Therapeutics NKTR:US $ 1056.15M 42.9M
Novartis NOVN:VX 23.81B 1.61B
Ptc Therapeutics PTCT:US $ 1066.23M 56.13M
Regeneron Pharmaceuticals REGN:US $ 13337.6M 3282.5M
Sangamo Biosciences SGMO:US $ 554.06M 52.88M
Sarepta Therapeutics SRPT:US $ 2265.22M 6.13M
Seattle Genetics SGEN:US $ 3098.51M 5.18M
Ultragenyx Pharmaceutical RARE:US $ 949.49M 121.44M
Vertex Pharmaceuticals VRTX:US $ 8457.51M 81.79M
YTE INCY:US $ 2620.06M 170.09M